← Eichor
Study identifier: NCT07526506 Synced from ClinicalTrials.gov · July 30, 2026
● Recruiting

Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers

Condition: Healthy Volunteer  ·  Sponsor: Traws Pharma, Inc.

PhasePhase 1
Planned participants24
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

This is a Phase 1b, randomized, double-blind, placebo-controlled, dose escalation study of TRX-100 tablets evaluating the safety, pharmacokinetics, and food effect of single ascending doses of TRX-100 in healthy volunteers.

This description comes directly from the study's public registry record.

Talk to the study team

Ekaterina Dokukina  ·  +38269728309  ·  kdokukina@eilenther.com

Always discuss trial participation with your own doctor first.

Locations (1)

Scientia Clinical Research Ltd.Randwick, New South Wales, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07526506